In the first demonstration of the potential for CAR-T therapy for previously untreatable advanced thyroid cancers, researchers from the Meyer Cancer Center were able to eliminate cancerous cells in cultures and mice. Read more
Women with a healthy body mass index (BMI) may be at risk of developing breast cancer because of enlarged fat cells in their breast tissue that trigger an inflammatory process, according to Andrew Dannenberg, M.D. Read more
A computational tool created by graduate students predicts how people’s livers, hearts and other tissues might respond to different drugs, in order to ID potentially dangerous side effects before the drugs are tested in people. Read more
Ekta Khurana, Ph. D., assistant professor of computational genomics has created a computational tool that can mine terabytes of overlooked genomic data to uncover potentially unknown drivers of cancer. Read more
Ithaca associate Claudia Fischbach-Teschl, Ph.D., has secured more than $1 million in funding from the Human Frontier Science Program (HFSP) to study breast cancer’s effect on the mineralization pathways in bone. Read more
A substantial N.I.H. budget cut would undermine the fiscal stability of universities and medical schools, many of which depend on N.I.H. funding; it would erode America’s leadership in medical research; and it would diminish opportunities to discover new ways to prevent and treat diseases, argues Harold Varmus, M.D. Read more
Patient-derived organoids are allowing researchers and clinicians to take precision medicine to the next level, according to a new paper by Mark Rubin and Lewis Cantley. Read more
David Lyden and Haiying Zhang received two grants from the Sohn Conference Foundation to advance their investigation into how cancer spreads in children. Read more
A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists . Their findings could pave... Read more
A research team led by Mark Rubin and Chris Barbieri found that the SPOP mutation leads to prostate cancer that grows in a distinctively different way from other common subtypes. Read more
Richard Silver, M.D., discusses the success of Gleevac, the once-a-day pill that has turned chronic myelogenous leukemia, or CML, from a certain death sentence into a manageable disease. Read more
Weill Cornell Medicine researchers will receive a grant from the Department of Defense to conduct an in-depth study of the molecular machinery driving the most aggressive form of prostate cancer. Most prostate cancers are a... Read more
David Rickman and Himisha Beltran will receive a grant from the Department of Defense to conduct an in-depth study of N-Myc and the molecular machinery driving neuroendocrine prostate cancer. Read more
NEW YORK (March 3, 2017) — Dr. Virginia Pascual, a renowned physician-scientist specializing in pediatric rheumatology, has been appointed the founding Gale and Ira Drukier Director of the Gale and Ira Drukier Institute for... Read more